BioSpace News Archive

InDex Pharmaceuticals Holding AB (publ) today announced an updated timeline for patient recruitment in the ongoing phase IIb study CONDUCT with the drug candidate cobitolimod.

As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level.

Market leaders in temperature-controlled microscopy and leaders in sample characterization solutions, Linkam Scientific Instruments, reports on the research of Professor Xiaoming “Shawn” He of the Fischell Department of Bioengineering at the University of Maryland.

The ONCOdianova GmbH (www.oncodianova.com), a newly founded Biotechnology Company from Hamburg, focuses on the specific analysis of immune-checkpoint-proteins in tumor tissues using antibodies. ONCOdianova has the vision to provide the best primary antibodies for the detection of immune-checkpoint-marker in the tumor tissue. The aim: To support the development of new cancer medication at the best.

Record Revenue from Domestic Sales up 29%; Expands Placements with New Retailers and Continues Strong Growth in Existing Accounts; Timing Shifts Sales from Second to Third Quarter

Company to relist on the New York Stock Exchange in mid-September

Conference call scheduled for 4:30 p.m. ET today

Universal Display Corporation announced that its Board of Directors approved a third quarter cash dividend of $0.06 per share on the Company’s common stock.

An oral presentation of updated Phase 2 poziotinib data including EGFR and HER2 patients with exon 20 mutations will occur on September 24 at the World Conference on Lung Cancer in Toronto

Alpine Immune Sciences, Inc. provided a corporate update and reported financial results for the second quarter ended June 30, 2018.